Redweik Graham A J, Horak Mary Kate, Hoven Ryley, Ott Logan, Mellata Melha
Department of Food Science and Human Nutrition, College of Agriculture and Life Sciences, Iowa State University, Ames, IA, United States.
Interdepartmental Microbiology Graduate Program, Iowa State University, Ames, IA, United States.
Front Microbiol. 2021 Jan 14;11:625286. doi: 10.3389/fmicb.2020.625286. eCollection 2020.
Chicken intestinal are a reservoir for virulence and antimicrobial resistance (AMR) genes that are often carried on incompatibility group F (IncF) plasmids. The rapid transfer of these plasmids between bacteria in the gut contributes to the emergence of new multidrug-resistant and virulent bacteria that threaten animal agriculture and human health. Thus, the aim of the present study was to determine whether live bacterial prophylactics could affect the distribution of large virulence plasmids and AMR in the intestinal tract and the potential role of smRNA in this process. In this study, we tested ∼100 randomly selected from pullet feces ( = 3 per group) given no treatment (CON), probiotics (PRO), a live vaccine (VAX), or both (P + V). isolates were evaluated via plasmid profiles and several phenotypic (siderophore production and AMR), and genotypic (PCR for virulence genes and plasmid typing) screens. P + V isolates exhibited markedly attenuated siderophore production, lack of AMR and virulence genes, which are all related to the loss of IncF and ColV plasmids ( < 0.0001). To identify a causal mechanism, we evaluated smRNA levels in the ceca mucus and found a positive association between smRNA concentrations and plasmid content, with both being significantly reduced in P + V birds compared to other groups ( < 0.01). To test this positive association between IncF plasmid transfer and host smRNA concentration, we evenly pooled smRNA per group and treated mating pairs with serial concentrations of smRNA . Higher smRNA concentrations resulted in greater rates of IncF plasmid transfer between donors (APEC O2 or VAX isolate IA-EC-001) and recipient (HS-4) (all groups; < 0.05). Finally, RNAHybrid predictive analyses detected several chicken miRNAs that hybridize with pilus assembly and plasmid transfer genes on the IncF plasmid pAPEC-O2-R. Overall, we demonstrated P + V treatment reduced smRNA levels in the chicken ceca, which was associated with a reduction in potentially virulent . Furthermore, we propose a novel mechanism in which intestinal smRNAs signal plasmid exchange between . Investigations to understand the changes in bacterial gene expression as well as smRNAs responsible for this phenomenon are currently underway.
鸡肠道是毒力基因和抗微生物耐药性(AMR)基因的储存库,这些基因通常携带在不相容性F组(IncF)质粒上。这些质粒在肠道细菌之间的快速转移促使新的多重耐药和有毒力细菌出现,威胁到动物养殖业和人类健康。因此,本研究的目的是确定活细菌预防性制剂是否会影响肠道中大型毒力质粒和AMR的分布,以及小RNA(smRNA)在此过程中的潜在作用。在本研究中,我们测试了从未经处理(CON)、给予益生菌(PRO)、活疫苗(VAX)或两者皆给予(P + V)的小母鸡粪便中随机挑选的约100株细菌(每组n = 3)。通过质粒图谱以及几种表型(铁载体产生和AMR)和基因型(毒力基因PCR和质粒分型)筛选对分离株进行评估。P + V分离株表现出明显减弱的铁载体产生、缺乏AMR和毒力基因,这些都与IncF和ColV质粒的丢失有关(P < 0.0001)。为了确定因果机制,我们评估了盲肠黏液中的smRNA水平,发现smRNA浓度与质粒含量之间呈正相关,与其他组相比,P + V组鸡的两者均显著降低(P < 0.01)。为了测试IncF质粒转移与宿主smRNA浓度之间的这种正相关关系,我们将每组的smRNA均匀混合,并使用系列浓度的smRNA处理交配的细菌对。较高的smRNA浓度导致IncF质粒在供体(禽致病性大肠杆菌O2或VAX分离株IA - EC - 001)和受体(HS - 4)之间的转移率更高(所有组;P < 0.05)。最后,RNAHybrid预测分析检测到几种与IncF质粒pAPEC - O2 - R上的菌毛组装和质粒转移基因杂交的鸡微小RNA(miRNA)。总体而言我们证明P + V处理降低了鸡盲肠中的smRNA水平,这与潜在有毒力细菌的减少有关。此外,我们提出了一种新机制,即肠道smRNA发出细菌间质粒交换的信号。目前正在进行研究以了解细菌基因表达的变化以及导致这种现象的smRNA。